Articles with "pvtt" as a keyword



Photo by averey from unsplash

The possibility of radiotherapy as downstaging to living donor liver transplantation for hepatocellular carcinoma with portal vein tumor thrombus

Sign Up to like & get
recommendations!
Published in 2017 at "Liver Transplantation"

DOI: 10.1002/lt.24729

Abstract: Hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) are difficult to manage with very poor survival and due to universal recurrence after liver transplantation, they have been excluded from indication. Conformer radiation therapy (RT)… read more here.

Keywords: hepatocellular carcinoma; pvtt; portal vein; liver transplantation ... See more keywords
Photo by alleslea from unsplash

Neoadjuvante Radiotherapie verbessert beim resezierbaren hepatozellulären Karzinom mit Portalvenen-Tumorthrombus das Gesamtüberleben und das krankheitsfreie Intervall

Sign Up to like & get
recommendations!
Published in 2019 at "Strahlentherapie und Onkologie"

DOI: 10.1007/s00066-019-01570-2

Abstract: Hintergrund Das hepatozelluläre Karzinom (HCC) ist weltweit die dritthäufigste Ursache, an Krebs zu versterben. Es neigt dazu, in das portalvenöse System einzubrechen und Portalvenen-Tumorthromben (PVTT) zu bilden. Während die stereotaktische Radiotherapie (SBRT) im Vergleich zum… read more here.

Keywords: radiotherapie; die; pvtt; einer ... See more keywords
Photo by portablepeopleproductions from unsplash

Impact of Hepatectomy for Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombus

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of Gastrointestinal Surgery"

DOI: 10.1007/s11605-021-05181-0

Abstract: Optimal treatment strategies for advanced hepatocellular carcinoma (HCC) with macroscopic portal vein tumor thrombus (PVTT) remain controversial. Therefore, this study aimed to assess the impact and predictive factors of hepatectomy for HCC with macroscopic PVTT.… read more here.

Keywords: hepatocellular carcinoma; pvtt; impact; portal vein ... See more keywords
Photo by arunwithideas from unsplash

A systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis.

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of gastroenterology and hepatology"

DOI: 10.1111/jgh.15010

Abstract: BACKGROUND The prognosis of hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is very poor. This study aimed to evaluate hepatic arterial infusion chemotherapy (HAIC) versus sorafenib (SORF) in the treatment of HCC with… read more here.

Keywords: hepatocellular carcinoma; pvtt; systematic review; sorf ... See more keywords
Photo by bermixstudio from unsplash

Transarterial Radioembolization versus Tyrosine Kinase Inhibitor in Hepatocellular Carcinoma with Portal Vein Thrombosis.

Sign Up to like & get
recommendations!
Published in 2023 at "Clinical and molecular hepatology"

DOI: 10.3350/cmh.2023.0076

Abstract: Background and aims Transarterial radioembolization (TARE) has shown promising results in treating advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT). However, whether TARE can provide superior or comparable outcomes to tyrosine kinase inhibitor… read more here.

Keywords: hepatocellular carcinoma; tare; pvtt; group ... See more keywords
Photo by averey from unsplash

Hypofractionated Radiotherapy for Palliation of Main Portal Vein Tumor Thrombosis

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2022.882272

Abstract: Background Hypofractionated radiotherapy delivered for portal vein tumor thrombosis (PVTT) located in the main portal vein is rarely exploited. The study aimed to evaluate the efficacy and safety of hypofractionated radiotherapy as palliative treatment for… read more here.

Keywords: main portal; pvtt; portal vein; tumor ... See more keywords
Photo by polarmermaid from unsplash

A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus

Sign Up to like & get
recommendations!
Published in 2022 at "Cancers"

DOI: 10.3390/cancers14153619

Abstract: Simple Summary Portal vein tumor thrombosis (PVTT) is the commonest type of macrovascular invasion in hepatocellular carcinoma (HCC), while the effectiveness of treatments for HCC with PVTT remains unsatisfactory. The present study aimed to assess… read more here.

Keywords: pvtt; tace; combination; therapy ... See more keywords